Ambev
ABEV
286 hedge funds and large institutions have $4.16B invested in Ambev in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 110 increasing their positions, 86 reducing their positions, and 32 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 86
13% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 32
12% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $11.1M
12% more capital invested
Capital invested by funds: $3.73B → $4.16B (+$433M)
1% more funds holding
Funds holding: 283 → 286 (+3)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.13% less ownership
Funds ownership: 8.48% → 8.35% (-0.13%)
Top Buyers
| 1 |
First Eagle Investment Management
New York
|
+$122M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$54.6M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$39.1M |
| 4 |
BlackRock
New York
|
+$21.1M |
| 5 |
JP Morgan Chase
New York
|
+$12.8M |
Top Sellers
ABEV Hedge Fund Activity: Q1 2022 in Review
286 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Ambev (ABEV) for Q1 2022, worth a combined $4.16B — up 12% from $3.73B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new ABEV positions and 32 closed out — a net gain of 4 holders — while 110 added to existing stakes and 86 trimmed.
The largest buyer was First Eagle Investment Management, adding an estimated $122M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $67.4M sold.
- 286 institutional investors held Ambev (ABEV) as of Q1 2022, up from 283 in Q4 2021.
- Funds reported $4.16B of Ambev stock for Q1 2022, up 12% quarter-over-quarter.
- 36 funds opened new Ambev positions in Q1 2022 and 32 closed out, a net change of +4 holders.
- The largest Ambev buyer in Q1 2022 was First Eagle Investment Management, an estimated $122M added.
- The largest Ambev seller in Q1 2022 was Arrowstreet Capital, an estimated $67.4M sold.
Based on aggregated 13F filings for Q1 2022.